Patent · US Active

Modified polynucleotides encoding hepatitis A virus cellular receptor 2

US9675668B2 · kind B2 · utility

96Cited by

401References

14Claims

0Family size

Assignee

Moderna Therapeutics, Inc. · US

Inventors

Stephane Bancel · Cambridge, US
Tirtha Chakraborty · Medford, US
Antonin de Fougerolles · Waterloo, BE
Susan Whoriskey · Belmont, US
Ron Weiss · Newton, US

Key dates

Filing date	Dec 13, 2013
Grant date	Jun 13, 2017
Priority date	—
Expiry date	Feb 13, 2035

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to compositions and methods for the preparation, manufacture and therapeutic use of polynucleotides, primary transcripts and mmRNA molecules.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.